These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 7879210
1. Anti-LFA-1 adhesion molecule monoclonal antibody in prophylaxis of human kidney allograft rejection. Le Mauff B, Hourmant M, Le Meur Y, Dantal J, Cantarovich D, Caudrelier P, Alberici G, Soulillou JP. Transplant Proc; 1995 Feb; 27(1):865-6. PubMed ID: 7879210 [No Abstract] [Full Text] [Related]
4. Rescue of severe steroid-resistant rejection with OKT3.PAN. Ponticelli C, Rivolta E, Tarantino A, De Vecchi A, Vegeto A. Transplant Proc; 1987 Feb; 19(1 Pt 3):1908-9. PubMed ID: 3274449 [No Abstract] [Full Text] [Related]
12. Role of interferon alpha in allograft rejection. Benizri EJ, Gugenheim J, Bernard G, Tovey MG. Transplant Proc; 1995 Feb; 27(1):413. PubMed ID: 7879043 [No Abstract] [Full Text] [Related]
13. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial. van Gelder T, Zietse R, Yzermans JN, Rischen-Vos J, Vaessen LM, Weimar W. Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247 [No Abstract] [Full Text] [Related]
14. Use of an anti-LFA-1 antibody in renal allograft rejection in sheep. Grooby WL, Carter JK, Rao MM, Dewan P, Seymour AE, Brandon M, Russ GR. Transplant Proc; 1992 Oct; 24(5):2304. PubMed ID: 1413070 [No Abstract] [Full Text] [Related]
15. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance. Taube D, Welsh KI, Bewick M, Dische FE, Palmer A, Parsons V, Snowden S. Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456 [No Abstract] [Full Text] [Related]
16. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Lazarovits AI, Poppema S, Zhang Z, Khandaker M, Le Feuvre CE, Singhal SK, Garcia BM, Ogasa N, Jevnikar AM, White MH, Singh G, Stiller CR, Zhong RZ. Nature; 1996 Apr 25; 380(6576):717-20. PubMed ID: 8614467 [Abstract] [Full Text] [Related]
17. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years. Sharma LC, Muirhead N, Lazarovits AI. Transplant Proc; 1997 Apr 25; 29(1-2):323-4. PubMed ID: 9123021 [No Abstract] [Full Text] [Related]
18. CD45RB monoclonal antibody induces tolerance in the mouse kidney graft, but fails to prevent small bowel graft rejection. Zhang Z, Lazarovits A, Grant D, Garcia B, Stiller C, Zhong R. Transplant Proc; 1996 Oct 25; 28(5):2514. PubMed ID: 8907929 [No Abstract] [Full Text] [Related]
19. Antibody-mediated rejection: treatment alternatives and outcomes. Singh N, Pirsch J, Samaniego M. Transplant Rev (Orlando); 2009 Jan 25; 23(1):34-46. PubMed ID: 19027615 [Abstract] [Full Text] [Related]
20. Reversal of allograft rejection using the monoclonal antibody, Campath-1G. Friend PJ, Waldmann H, Hale G, Cobbold S, Rebello P, Thiru S, Jamieson NV, Johnston PS, Calne RY. Transplant Proc; 1991 Aug 25; 23(4):2253-4. PubMed ID: 1908152 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]